Biodesix, Inc. (BDSX)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$21.90
+2.99%
Mkt Cap $154.34M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$31.00
Range $26.00 – $35.00
Implied Upside
+41.6%
Consensus $31.00 vs current $21.90